Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huizhou Jiuzhou Pharmaceutical, formerly known as Guangdong Huizhou Traditional Chinese Medicine Factory, is a pharmaceutical company headquartered in Huizhou, Guangdong Province, China. Founded in 1970 as a state-owned enterprise, it underwent a significant restructuring in 1998 to become a joint-stock company. The company specializes in the development and production of Traditional Chinese Medicine (TCM) and integrated Chinese-Western medicines, particularly for gastrointestinal and respiratory health. Its flagship product, the Anwei Yangrong Capsule, is widely recognized in China for the treatment of gastric and duodenal ulcers. The firm operates modern manufacturing facilities that are GMP-certified for various dosage forms, including capsules, tablets, granules, and oral liquids. Jiuzhou Pharmaceutical maintains a strong regional presence and continues to invest in the modernization of traditional herbal formulas through its dedicated R&D center.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 广东省惠州市中药厂.